Joyce Chan, PHARMD | |
58 Golden Aster Ct, Brisbane, CA 94005-1283 | |
(415) 859-9048 | |
Not Available |
Full Name | Joyce Chan |
---|---|
Gender | Female |
Speciality | Pharmacist |
Location | 58 Golden Aster Ct, Brisbane, California |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508135971 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
183500000X | Pharmacist | 54506 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Joyce Chan, PHARMD 58 Golden Aster Ct, Brisbane, CA 94005-1283 Ph: (415) 859-9048 | Joyce Chan, PHARMD 58 Golden Aster Ct, Brisbane, CA 94005-1283 Ph: (415) 859-9048 |
News Archive
In response to the current trend toward personalized medicine, the Beaumont Weight Control Center, affiliated with Beaumont Hospitals, a major Detroit-area health system, now offers individualized MicroNutrient Testing for patients.
U.S. Department of Health and Human Services (HHS) Secretary Kathleen Sebelius today issued a letter to governors and independent insurance commissioners asking each state to express their interest in participating in the temporary high risk pool program established by the new health insurance reform law. The temporary high risk pool program was created to help provide coverage to people who are uninsured because of pre-existing conditions. States may choose whether and how they participate in the program.
RNA-based drugs have the potential to change the standard of care for many diseases, making personalized medicine a reality. This rapidly expanding class of therapeutics are cost-effective, fairly easy to manufacture, and able to go where no drug has gone before, reaching previously undruggable pathways.
In this article in the online journal Global Health Governance, David Fidler, a professor at the Indiana University Maurer School of Law, writes about the Republican presidential candidates' positions on global health, saying, "I doubt whether many votes in subsequent GOP primaries will be cast because of global health considerations."
Findings from the early phase of a clinical trial led by Johns Hopkins investigators indicates that a new, minimally invasive weight loss treatment known as bariatric arterial embolization is safe and effective in sustaining weight loss in severely obese people.
› Verified 4 days ago